Talis Biomedical's Grant - II Round

Talis Biomedical raised a round of funding on June 13, 2018. Investors include National Institute of Allergy and Infectious Diseases.

Talis Bio is developing a high-performance molecular point-of-care (POC) diagnostic platform to enable physician offices and clinics to run reference lab-quality diagnostic laboratory tests for infect…

Articles about Talis Biomedical's Grant - II Round: